Breast Conservation After Neoadjuvant Chemotherapy for Triple-Negative Breast Cancer: Surgical Results From the BrighTNess Randomized Clinical Trial

IMPORTANCE: Neoadjuvant systemic therapy (NST) is often administered to enable breast-conserving therapy (BCT) in stages II to III breast cancer. OBJECTIVES: To prospectively evaluate the role of NST in conversion from BCT ineligibility to BCT eligibility and to assess the association of response to...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of surgery (Chicago. 1960) 2020-03, Vol.155 (3), p.e195410-e195410
Hauptverfasser:	Golshan, Mehra, Loibl, Sibylle, Wong, Stephanie M, Huober, Jens Bodo, O’Shaughnessy, Joyce, Rugo, Hope S, Wolmark, Norman, McKee, Mark D, Maag, David, Sullivan, Danielle M, Metzger-Filho, Otto, Von Minckwitz, Gunter, Geyer, Charles E, Sikov, William M, Untch, Michael
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Breast cancer Cancer surgery Chemotherapy Chemotherapy, Adjuvant Double-Blind Method Female Humans Mastectomy, Segmental Middle Aged Neoadjuvant Therapy Online First Online Only Original Investigation Patient Selection Prospective Studies Treatment Outcome Triple Negative Breast Neoplasms - drug therapy Triple Negative Breast Neoplasms - surgery Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!